Lipid Mediators of Inflammation and Resolution in Individuals with Tuberculosis and Tuberculosis-Diabetes

Individuals with concurrent tuberculosis (TB) and Type 2 diabetes (DM) have a higher risk of adverse outcomes. To better understand potential immunological differences, we utilized a comprehensive panel to characterize pro-inflammatory and pro-resolving (i.e., mediators involved in the resolution of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Prostaglandins Other Lipid Mediat
Egile Nagusiak: Shivakoti, Rupak, Dalli, Jesmond, Kadam, Dileep, Gaikwad, Sanjay, Barthwal, Madhusudan, Colas, Romain A., Mazzacuva, Francesca, Lokhande, Rahul, Dharmshale, Sujata, Bharadwaj, Renu, Kagal, Anju, Pradhan, Neeta, Deshmukh, Sona, Atre, Sachin, Sahasrabudhe, Tushar, Kakrani, Arjun, Kulkarni, Vandana, Raskar, Swapnil, Suryavanshi, Nishi, Chon, Sandy, Gupte, Akshay, Gupta, Amita, Gupte, Nikhil, Arriaga, María B., Fukutani, Kiyoshi F., Andrade, Bruno B., Golub, Jonathan E., Mave, Vidya
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7067657/
https://ncbi.nlm.nih.gov/pubmed/31726221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prostaglandins.2019.106398
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak